Adagio Medical raises $42.5m in Series E to transform cardiac ablation treatment
Adagio Medical, a California-based medical device company specializing in innovative treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), has successfully raised $42.5 million in ... Read More
Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates
Lyra Therapeutics has raised $30 million in a Series C financing round to advance its lead product candidates for the treatment of chronic rhinosinusitis (CRS). ... Read More
4D Molecular Therapeutics secures $90m in Series B to advance gene therapy innovations
California-based 4D Molecular Therapeutics (4DMT), specializing in adeno-associated virus (AAV) gene therapy vector discovery and product development, has successfully raised $90 million through a Series ... Read More